-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Amylyx Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q2 2024.
- Amylyx Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $9.57M, a 3.82% decline year-over-year.
- Amylyx Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $39.2M, a 34.9% increase year-over-year.
- Amylyx Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $37.2M, a 71.1% increase from 2022.
- Amylyx Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $21.7M, a 592% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)